Relief of overall pain ‐ reported as pelvic pain ‐ 3 months · women with endometriosis
GnRHas may leads to higher relief of overall pain ‐ reported as pelvic pain ‐ 3 months compared with placebo (low certainty).
1 finding from 1 review
Relief of painful symptoms ‐ Dysmenorrhoea · women with endometriosis
GnRHas may leads to higher relief of overall pain ‐ reported as dysmenorrhoea ‐ 3 months compared with placebo (low certainty).
1 finding from 1 review
Relief of overall pain ‐ reported as dyspareunia ‐ 3 months · women with endometriosis
GnRHas may leads to higher relief of overall pain ‐ reported as dyspareunia ‐ 3 months compared with placebo (low certainty).
1 finding from 1 review
Relief of overall pain ‐ reported as pelvic tenderness ‐ 6 months · women with endometriosis
GnRHas may leads to higher relief of overall pain ‐ reported as pelvic tenderness scores‐ 3… compared with placebo (low certainty).
1 finding from 1 review
Relief of overall pain ‐ reported as pelvic induration ‐ 6 months · women with endometriosis
GnRHas showed no clear difference in relief of overall pain ‐ reported as pelvic induration scores ‐ 3… compared with placebo (low certainty).
1 finding from 1 review
Pain intensity VAS (0 to 100; 0 = no pain, 100 = worst pain) · adults with low back pain
1 finding from 1 review
Disability (Roland‐Morris Disability Questionnaire) Scale from: 0 to 23; 0 is no disability. · adults with low back pain
1 finding from 1 review
QoL · adults with low back pain
1 finding from 1 review
Global assessment of efficacy ≥ 50% improvement in pain Medium‐term · adults with low back pain
1 finding from 1 review
Withdrawals due to adverse events · adults with low back pain
1 finding from 1 review
Adverse eventsc · adults with low back pain
1 finding from 1 review
Serious adverse eventsd · adults with low back pain
1 finding from 1 review
Pain (PIPP) · neonates
3 findings from 1 review
no estimate extracted
7 studies · 547 participants
Moderate
no estimate extracted
3 studies · 227 participants
Low
no estimate extracted
2 studies · 164 participants
Moderate
PIPP ‐ Preterm infants · neonates
1 finding from 1 review
DAN scores at 30 seconds after heel lancing (term infants)Scale from: 0 to 10 · neonates
1 finding from 1 review
Neonatal Infant Pain Scale (NIPS) · neonates
1 finding from 1 review
Fatigue · systemic lupus erythematosus
1 finding from 1 review
Functional capacity · systemic lupus erythematosus
1 finding from 1 review
Pain (SF‐36 Bodily Pain domain, score 0‐100, lower scores indicate less pain) · systemic lupus erythematosus
1 finding from 1 review
Disease activity ‐ not measured · systemic lupus erythematosus
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found